News | May 02, 2011

First Patients Enrolled in Study of Self-Apposing Coronary Stent

May 2, 2011 – The mid-point for enrollment was reached in of the international APPOSITION III study of Stentys self-apposing coronary stent. About 250 patients are now enrolled out of a total of 500. The trial primary endpoint is major adverse cardiac events (MACE) at 12 months post-procedure.
 
“All cardiologists are extremely excited to be part of the APPOSITION III study and to routinely use the Stentys Self-Apposing Stent in treating AMI patients,” said study investigator Robert Jan van Geuns, M.D., Ph.D., Thorax Center at Erasmus Medical Center, Rotterdam, the Netherlands.
 
The stent is self-apposing to fit snugly into the contour of a blood vessel. Its shape and diameter adapt to the anatomic changes of the coronary arteries during the post-acute myocardial infarction (AMI) phase. The APPOSITION II randomized trial compared the Self-Apposing Stent with a conventional, market-leading stent in patients suffering a heart attack. It showed that, three days after an AMI, 28 percent of patients treated with conventional stents displayed significant malapposition, meaning that the stent was not completely in contact with the artery wall. Malapposition puts AMI patients at significant risk of potential fatal complications such as a blockage of the stent (in-stent thrombosis). In contrast, none of the patients treated with the Stentys stent had stent malapposition.
 
For more information: www.stentys.com

Related Content

RamSoft Reaches Distribution Agreement With Medical Equipment Dynamics
News | PACS | September 21, 2017
September 21, 2017 — Medical Equipment Dynamics, provider of new, used and refurbished medical equipment, will now of
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
The Endless Possibilities Created by a Cross-Enterprise Workflow
Sponsored Content | Case Study | Cross-enterprise Imaging | September 19, 2017
Located in Fort Collins, Colo., Advanced Medical Imaging Consultants (AMIC) is the exclusive medical imaging provider
Telemis Supplying Complete PACS to French Radiology Group
News | PACS | September 18, 2017
Telemis announced that the Groupement Radiologues Associés (GRA) in Bordeaux, France, chose Telemis's picture archiving...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
News | PACS | September 13, 2017
Nuance Communications Inc. announced that Citizens Medical Center, a critical access hospital in rural Kansas, has...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Fujifilm Secures DIN-PACS IV Contract From U.S. Department of Defense
News | Enterprise Imaging | September 12, 2017
September 12, 2017 — Fujifilm Medical Systems U.S.A.
Overlay Init